Updates in the Management of Myelofibrosis


SIMPLIFY-2 Trial: Momelotinib Vs. Continued Ruxolitinib or Best Available Therapy in Pts With MF Who Require RBC Transfusions

297 views
June 28, 2024
Comments 0
Login to view comments. Click here to Login